Letter

Patients often present too late for inclusion in trials

BMJ 1995; 311 doi: 10.1136/bmj.311.7019.1570b (Published 9 December 1995)
Cite this as: BMJ 1995;311:1570.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. S Dische,
  2. D Gibson,
  3. M Parmar,
  4. M I Saunders,
  5. A Barrett
  1. (Chairman) CHART Steering Committee, Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex HA6 2RN

    EDITOR,--Heather Goodare and Richard Smith encourage patients to become involved in the establishment as well as the performance of clinical trials.1 In prospective randomised controlled clinical trials in malignant disease, patients are in general well prepared to cooperate and participate. However, they must first reach the treatment centre at a time when their condition is suitable for inclusion.

    The randomised controlled …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular